78 related articles for article (PubMed ID: 23824897)
1. Mouse model of invasive fungal infection.
MacCallum DM
Methods Mol Biol; 2013; 1031():145-53. PubMed ID: 23824897
[TBL] [Abstract][Full Text] [Related]
2. Mouse intravenous challenge models and applications.
MacCallum DM
Methods Mol Biol; 2012; 845():499-509. PubMed ID: 22328398
[TBL] [Abstract][Full Text] [Related]
3. A Mouse Model of Candidiasis.
Fajardo P; Cuenda A; Sanz-Ezquerro JJ
Methods Mol Biol; 2021; 2321():63-74. PubMed ID: 34048008
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the pathogenicities of Fusarium solani and Candida albicans in the rabbit cornea.
Ishibashi Y; Kaufman HE; Kagawa S
J Med Vet Mycol; 1986 Oct; 24(5):369-76. PubMed ID: 3537261
[TBL] [Abstract][Full Text] [Related]
5. Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice.
Brieland J; Essig D; Jackson C; Frank D; Loebenberg D; Menzel F; Arnold B; DiDomenico B; Hare R
Infect Immun; 2001 Aug; 69(8):5046-55. PubMed ID: 11447185
[TBL] [Abstract][Full Text] [Related]
6. Effect of farnesol on a mouse model of systemic candidiasis, determined by use of a DPP3 knockout mutant of Candida albicans.
Navarathna DH; Hornby JM; Krishnan N; Parkhurst A; Duhamel GE; Nickerson KW
Infect Immun; 2007 Apr; 75(4):1609-18. PubMed ID: 17283095
[TBL] [Abstract][Full Text] [Related]
7. Temporal events in the intravenous challenge model for experimental Candida albicans infections in female mice.
MacCallum DM; Odds FC
Mycoses; 2005 May; 48(3):151-61. PubMed ID: 15842329
[TBL] [Abstract][Full Text] [Related]
8. Visualizing fungal infections in living mice using bioluminescent pathogenic Candida albicans strains transformed with the firefly luciferase gene.
Doyle TC; Nawotka KA; Kawahara CB; Francis KP; Contag PR
Microb Pathog; 2006 Feb; 40(2):82-90. PubMed ID: 16426810
[TBL] [Abstract][Full Text] [Related]
9. Candida albicans strain-dependent virulence and Rim13p-mediated filamentation in experimental keratomycosis.
Mitchell BM; Wu TG; Jackson BE; Wilhelmus KR
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):774-80. PubMed ID: 17251477
[TBL] [Abstract][Full Text] [Related]
10. Animal models of candidiasis.
Clancy CJ; Cheng S; Nguyen MH
Methods Mol Biol; 2009; 499():65-76. PubMed ID: 19152040
[TBL] [Abstract][Full Text] [Related]
11. The changing epidemiology of invasive fungal infections: new threats.
Maschmeyer G
Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():3-6. PubMed ID: 16707250
[TBL] [Abstract][Full Text] [Related]
12. Immunisation with the glycolytic enzyme enolase confers effective protection against Candida albicans infection in mice.
Li Wq; Hu Xc; Zhang X; Ge Y; Zhao S; Hu Y; Ashman RB
Vaccine; 2011 Jul; 29(33):5526-33. PubMed ID: 21645574
[TBL] [Abstract][Full Text] [Related]
13. Plant production of anti-β-glucan antibodies for immunotherapy of fungal infections in humans.
Capodicasa C; Chiani P; Bromuro C; De Bernardis F; Catellani M; Palma AS; Liu Y; Feizi T; Cassone A; Benvenuto E; Torosantucci A
Plant Biotechnol J; 2011 Sep; 9(7):776-87. PubMed ID: 21265996
[TBL] [Abstract][Full Text] [Related]
14. Candida albicans gene expression in an in vivo infection model.
Kruppa MD
Methods Mol Biol; 2009; 499():77-83. PubMed ID: 19152041
[TBL] [Abstract][Full Text] [Related]
15. The effect of Candida albicans systemic infection on matrix metalloproteinases in breast cancer bearing BALB/c mice.
Hajari Taheri F; Seyedolmohadesin M; Bayat M; Mahdavi M; Yazdi MH; Eslamifar A; Abolhasani M
Iran J Allergy Asthma Immunol; 2013 Mar; 12(1):81-5. PubMed ID: 23454783
[TBL] [Abstract][Full Text] [Related]
16. The importance of strain variation in virulence of Candida dubliniensis and Candida albicans: results of a blinded histopathological study of invasive candidiasis.
Asmundsdóttir LR; Erlendsdóttir H; Agnarsson BA; Gottfredsson M
Clin Microbiol Infect; 2009 Jun; 15(6):576-85. PubMed ID: 19604278
[TBL] [Abstract][Full Text] [Related]
17. The pathogenicity of Beauveria bassiana in the rabbit cornea.
Ishibashi Y; Kaufman HE; Ichinoe M; Kagawa S
Mykosen; 1987 Mar; 30(3):115-26. PubMed ID: 3295537
[No Abstract] [Full Text] [Related]
18. Effect of exogenous administration of Candida albicans autoregulatory alcohols in a murine model of hematogenously disseminated candidiasis.
Martins M; Lazzell AL; Lopez-Ribot JL; Henriques M; Oliveira R
J Basic Microbiol; 2012 Aug; 52(4):487-91. PubMed ID: 22052380
[TBL] [Abstract][Full Text] [Related]
19. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice.
Huang W; Na L; Fidel PL; Schwarzenberger P
J Infect Dis; 2004 Aug; 190(3):624-31. PubMed ID: 15243941
[TBL] [Abstract][Full Text] [Related]
20. Candida albicans Sfl2, a temperature-induced transcriptional regulator, is required for virulence in a murine gastrointestinal infection model.
Song W; Wang H; Chen J
FEMS Yeast Res; 2011 Mar; 11(2):209-22. PubMed ID: 21205158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
